Interestingly, PRDX2 was upregulated in both insulin-sensitive and insulin-resistant patients, suggesting obesity as a major driver of PRDX2 upregulation (Fig. 4b). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.